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TLP1: A Gene Encoding a Protein Component
of Mammalian Telomerase Is a Novel Member
of WD Repeats Family
Jun-ichi Nakayama,* Motoki Saito,* major role in telomeric maintenance. This enzyme spe-
cifically adds telomeric repetitive DNA to the chromo-Hideo Nakamura,² Akira Matsuura,*
some 39 ends (Greider and Blackburn, 1985; for review,and Fuyuki Ishikawa*
see Blackburn, 1992). Telomerase was originally iso-*Department of Life Science
lated from the macronucleus of the ciliate Tetrahymena.Tokyo Institute of Technology
Elegant studies indicated that telomerase is a multiple-4259 Nagatsuta
component enzyme, with both RNA and protein compo-Midori-ku, Yokohama 226
nents essential for its activity (Greider and Blackburn,²Pharmaceutical Laboratory II
1987). The 159 nt RNA component serves as a templateYokohama Research Center
for synthesizing the Tetrahymena telomeric sequenceMitsubishi Chemical Corporation
(Greider and Blackburn, 1989; Shippen-Lentzand Black-1000 Kamoshida-cho
burn, 1990). Thus, telomerase is a specialized type ofAoba-ku, Yokohama 227
reverse transcriptase, containing an RNA template asJapan
an intrinsic component of the enzyme. Recently, the
genes encoding p80 and p95, two proteinaceous com-
ponents that copurify with Tetrahymena telomerase,
Summary have been isolated (Collins et al., 1995). p95 has a limited
homology with the consensus sequencesof thecatalytic
We have cloned and characterized the rat telomerase regions of the RNA and DNA polymerases. p80 was
protein component 1 gene (TLP1), which is related to shown to bind to the RNA component. More recently,
the gene for Tetrahymena p80. The cDNA encodes a two proteins of 120 and 43 kDa were identified as the
2629 amino acid sequence and produces the TLP1 telomerase components derived from another ciliate,
proteins p240 and p230. The anti-TLP1 antibody spe- Euplotes (Lingner and Cech, 1996).
cifically immunoprecipitated the telomerase activity. Telomerase activity has been detected in a wide vari-
Moreover, p240 and p230 were copurified with telo- ety of eukaryotic species, including yeasts, ciliates, Xe-
merase activity in a series of extensive purification nopus, mouse, and human (Morin, 1989; Mantell and
experiments. These results strongly suggest that the Greider, 1994; Cohn and Blackburn, 1995; Lin and Zak-
TLP1 proteins are components of, or are closely asso- ian, 1995; Lue and Wang, 1995; Prowse and Greider,
ciated with, the rat telomerase. A pulse-chase experi- 1995). In mammalian cells, however, there is much less
ment showed that p240 is modified to p230 in vivo. telomerase activity than in the Tetrahymena macro-
nuclei. Accordingly, only after the development of a sen-p230 was the dominant form in telomerase-positive
sitive PCR-based assay did studies on mammalian telo-cells, suggesting that modification of the TLP1 protein
merase become practical (Kim et al., 1994). High levelsmay regulate telomerase activity in vivo.
of telomerase activity were found in cancer and germ
cells, but only weak activity or no activity was generally
Introduction observed in normal somatic cells (for review, see Harley
and Villeponteau, 1995).
In the early 1970s, it was suggested that linear genomic Telomerase RNA subunits have been identified and
DNA loses terminal sequences each time it replicates, sequenced in several organisms. In spite of the wide
because DNA polymerases initiate de novo DNA synthe- prevalence of telomerases among the eukaryotic king-
sis in a unidirectional orientation from an RNA primer doms, it was surprising that these RNA components
(Watson, 1972; Olovnikov, 1973; Levy et al., 1992; Ling- have very different lengths and sequences (Lingner et
ner et al., 1995). The actual demonstration of this end al., 1994; Singer and Gottschling, 1994; Blasco et al.,
replication problem in vertebrates became possible with 1995; Feng et al., 1995; McEachern and Blackburn,
the identification of the human telomeric DNA se- 1995). Recent studies examining the expression of hu-
quences, which were found to be TTAGGG repeats man RNA component (hTR) showed no correlation be-
(Moyzis et al., 1988). Molecular studies using TTAGGG tween the hTR expression level and telomerase activity
probes then indicated that normal human somatic cells (Avilion et al., 1996). Thus, telomerase activity must be
typically lose terminal DNA sequences at a rate of 50± regulated by other mechanisms, presumably by protein
200 bp per population doubling (Harley et al., 1990; Has- components.
tie et al., 1990). In sharp contrast to somatic cells, germ We know very little about the biochemical and struc-
cells do not show any telomere reduction and maintain tural aspects of mammalian telomerases, because of
a long tract of repetitive telomere DNA, in spite of their the very low abundance of these enzymes. Attempts
extensive proliferation (Hastie et al., 1990). Many types to isolate the mammalian genes encoding telomerase
of cancer cells also do not show this loss of telomeric protein components by cross-hybridization using the
DNA. These cells continue to proliferate without appar- Tetrahymena p80 or p95 sequences have been unsuc-
ent telomere shortening (Counter et al., 1992). cessful.
It was presumed that some mechanism overcomes Here, we report the isolation of a rat cDNA that en-
the end replication problem in cells that maintain their codes an amino acid sequence related to Tetrahymena
p80. We provide evidence that this cDNA encodes atelomeric lengths. Telomerase is now known to play a
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protein that is one component of, or is closely associ-
ated with, the rat telomerase, and thus we have named
the gene telomerase protein component 1 (TLP1). Sur-
prisingly, the TLP1 proteins p240 and p230 are much
larger than p80 and contain functional domains not
found in p80. One domain consists of WD-40 repeats,
a motif known to mediate protein±protein interactions.
Results
One major difficulty in the biochemical study of the mam-
malian telomerase was the lack of a sensitive and quanti-
tative method for analyzing activity. We have developed
a new PCR-based detection method called the ªstretch
PCR assayº for this purpose (Tatematsu et al., 1996).
Using this method, we have succeeded in extensively
purifying mouse, rat, and human telomerases (unpub-
lished data; see Figure 4). We observed 2 or 3 major
protein molecules of about 55±60 kDa and a few minor
species of more than 200 kDa in these highly purified
telomerase samples. However, we were unable to obtain
amino acid sequence information from these purified
materials, owing to the scarcity of the proteins.
cDNA Cloning of a Rat Gene Related to p80
As a result of a database search for DNA sequences
homologous to the component genes for Tetrahymena
telomerase p80 or p95, we identified a rat EST (expres-
sion sequence tag) clone showing low homology with
p80. This cDNA clone, H33937 (GenBank ID), was origi-
nally cloned from a rat pheochromocytoma cell line
PC12 cDNA library as a part of the EST database project.
However, it initially seemed unlikely that this clone en-
coded the rat p80 homolog for two reasons. First, the Figure 1. Cloning of the Rat cDNA Related to Tetrahymena p80
open reading frameshowing homology with the Tetrahy- (A) The rat EST clone H33937 and the PCR clone V5 are schemati-
mena p80 protein was supposedly the antisense se- cally represented. The reported sequence of H33937 in the EST
database is antisense to the open reading frame encoding the ratquence of the cDNA clone. Second, there was an in-
p80-homologous amino acid sequence and contains an intron se-frame stop codon in the DNA region homologous to the
quence. The sequence of the splice acceptor site of the intron isgene for p80. We constructed an oligonucleotide primer,
shown at the top of the diagram, and the in-frame stop codon found
PC5, from the reported DNA sequence of H33937 and in H33937 is underlined. A vectorette PCR experiment using PC5
performed a vectorette PCR experiment (Figure 1A). and a vectorette primer (Vct) produced the fragment V5. V5 did not
Vectorette PCR utilizes one specific primer and one contain the intron or the stop codon and showed greater homology
with the Tetrahymena p80 sequence than the original H33937 ESTadaptor primer ligated to restricted DNA ends (Riley et
clone. At present, we do not know the detailed exon-intron struc-al., 1990). Since only one specific primer is needed for
tures of the gene, and the boxes shown as exons are drawn herethis type of PCR, it is possible to clone a DNA fragment
for clarity. The relative lengths and positions of the clones and the
including a contiguous region of unknown DNA se- exons are not to scale.
quence. Random-primed cDNA was synthesized from (B) Deduced amino acid sequence of the rat TLP1 protein. The 4
the mRNA derived from a rat adenovirus-transformed tandem repeats of the well-conserved 30 amino acid sequences
are underlined at the N-terminus. The region homologous with the3Y1 fibroblast cell line. Vectorette PCR using the PC5
Tetrahymena p80 protein is indicated by a shaded box.The Walker'sprimer and an adaptor primer produced a PCR fragment
A- and B-box sequences, which have been found in manynucleotideclone V5 from the cDNA. DNA sequencing of V5 identi-
binding proteins, are shown by dots and asterisks, respectively,
fied a 1181 bp DNA sequence. A 168 bp sequence start- indicating the conserved amino acids (Walker et al., 1982). The 16
ing from the PC5 primer of V5 was found to be identical WD-40 motifs at the C-terminus are underlined.
to H33937. However, the DNA sequence of the rest of
V5 was completely different from H33937. A tctctcctAG
sequence that was a good match with the consensus Importantly, the conceptually translated amino acid se-
quence from theV5 sequence showed greaterhomologysplicing acceptor site was found at the point where
homology between H33937 and V5 diverged (Figure 1A). with the Tetrahymena p80 protein (p, the probability that
the homology is coincidental, 5 9.1 3 1027) than theThese results were most simply explained by assuming
that V5 and H33937 were both derived from transcripts original H33937 sequence (p 5 0.0017).
We constructed a cDNA library from a rat SV40-trans-of a common rat gene, and that the reported DNA se-
quence of H33937 was antisense and included an intron. formed subline of 3Y1 fibroblasts (SV-3Y1-C66), inwhich
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we had previously detected potent telomerase activity. presence of at least 16 repeats in the C-terminus of the
rTLP1 protein. The number of these repeats in rTLP1 isV5 was used as a probe to screen 1 3 106 independent
clones, and 3 positive clones were identified. Further surprising, because in most WD repeats proteins, the
number of repeats has been reported to be between 5screening of the library using DNA probes constructed
from the ends of the longest cDNA clone identified a and 10 (Neer et al., 1994). The most C-terminal region
of the protein is also rich in tryptophan. This region maytotal of seven overlapping cDNA clones. The 59 end
of the cDNA clone was obtained by a 59 RACE (rapid contain remnants of additional WD-40 repeats or may
represent a totally unrelated structure.amplification of cDNA end) experiment. DNA sequenc-
ing was performed and a composite cDNA sequence of
8193 nt (from the 59 end of the 59 RACE clone to the 39
rTLP1 Protein Is Associatedend of the unique sequence, just upstream of the long
with the Rat Telomerasepoly[A] tract) was determined. Two observations sug-
To examine the role of the rTLP1 protein in telomerasegested that the cDNA sequence was not chimeric. First,
activity, we first raised rabbit antisera against recombi-restriction mapping of the seven clones indicated that
nant proteins representing the p80-homologous region.every region of the composite sequence was colinear in
To confirm that the purified antibody recognizes theat least two different cDNA clones. Second, a 59-terminal
rTLP1 protein, an immunoprecipitation experiment wasprobe (744±1955 nt) and a 39-terminal probe (6066±7424
performed (Figure 3). A mammalian expression plasmidnt) identified the same 9 kb mRNA in a Northern blotting
that produced the full-length rTLP1 protein fused withexperiment using total RNA from rat SV-3Y1-C66 cells
a FLAG tag (DYKDDDDK) at its C-terminus was trans-(data not shown). As described below, this cDNA en-
fected into COS7 cells. Cells transiently expressing thecodes one protein associated with the rat telomerase.
recombinant proteins were cultured in the presence ofHereafter, we will refer to this gene as rat telomerase
[35S]methionine and cysteine. Total cell lysates were pre-protein component 1 (rTLP1).
pared and immunoprecipitated by the anti-FLAG tag
antibody (Figure 3, lanes 1 and 2) or the affinity-purified
anti-rTLP1 antibody (Figure 3, lanes 3 and 4). Both anti-Structural Analysis of rTLP1 Protein
Figure 1B shows the 2629 aminoacid sequence concep- bodies specifically recognized a protein with an appar-
ent molecular mass of 240 kDa in the cDNA-transfectedtually translated from the determined rTLP1 cDNA se-
quence. The size of the predicted rTLP1 protein was COS7 cells (Figure 3, lanes 2 and 4), but not in the mock-
transfected cells (Figure 3, lanes 1 and 3). Any othercalculated to be 292 kDa. The most 59-terminal ATG
codon of thecDNA was tentatively assigned as the initia- protein recognized by the anti-FLAG or anti-rTLP1 anti-
body was present in both the mock- and cDNA-tion codon. The DNA sequence around this codon
(GCTATGG) matches well with the consensus DNA se- transfected cells and was not recognized simulata-
neously by both antibodies, indicating that the reactionsquence for the eukaryotic initiation codon. The exact
assignment of the initiation codon, however, awaits were nonspecific. This experiment confirmed that the
antibody we had raised actually recognized the rTLP1amino acid sequencing of the N-terminus of the protein
product. protein. The molecular mass of the rTLP1 protein calcu-
lated from its migration in SDS-PAGE (240 kDa) wasSeveral interesting features were observed in the de-
duced amino acid sequence of the rTLP1 protein (Figure significantly less than the calculated value (292 kDa). At
present, we do not know if this difference resulted from2A). First, amino acids 1±120 had 4 tandem repeats of
a well-conserved 30 amino acid sequence (Figure 2B). anomalous migration of the protein in the gel or from
translational initiation at a site other than that which weNo sequence with significant homology to this repeat
motif was identified in the GenBank database. The had tentatively assigned.
To determine whether the rTLP1 protein is involvedamino acid sequence of the TLP1 protein can be grossly
divided into three domains. The region comprising in telomerase activity, we examined fractions obtained
during the purification of rat AH66F cell telomerase foramino acids 200±908 shows significant homology with
the total sequence of the Tetrahymena telomerase p80 the presence of the rTLP1 protein. We have extensively
purified rat, mouse, and human telomerases using acomponent (p 5 3.3 3 10252; Figures 2A and 2C). A
potential metal-binding motif, CxxC(27)CxxC, has been combination of heparin-Sepharose, anion-exchange,
hydroxyapatite, and metal-chelate chromatography,described in p80 (Collins et al., 1995), but no similar
sequence was found in the rTLP1 sequence. Following and glycerol-gradient centrifugation (unpublished data).
The fractions obtained by these different separationthe p80-homologous region, a canonical ATP/GTP bind-
ing sequence is present in the middle region of the techniques were examined for the presence of the rTLP1
protein by Western blotting and were assayed for telo-protein (Walker et al., 1982) (Figure 2A). In the C-terminal
third of the protein, a characteristic spacing of trypto- merase activity by stretch PCR (Tatematsu et al., 1996).
Any PCR-based detection method is weak in quantita-phan (W) and aspartic acid (D) was noted (Figures 2A
and 2D). These W-D sequences, separated by about 40 tive ability, because it is difficult to control the efficiency
of exponential amplification reactions. The stretch PCRamino acids, are known as WD-40 repeats (Neer et al.,
1994). WD-40 repeats were first described for the b assay was developed to overcome this weakness as
much as possible by careful control studies (Tatematsusubunit of the heterotrimeric G protein complex (Fong
et al., 1986) and have a role in protein±protein interac- et al., 1996). We found that the assay is highly specific
and quantitative, and we were able to determine nottions. A consensus sequence for WD-40 repeats has
been deduced. An alignment of the rTLP1 amino acid only the presence or absence of telomerase activity
but also the relative titers of the activity in the purifiedsequence with the consensus sequence indicated the
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Figure 2. Domain Structures of the rTLP1
Protein
(A) The overall structure of the deduced rat
TLP1 amino acid sequence. The amino acid
sequence 200±908 shows homology with the
Tetrahymena p80 protein. The alignment of
rTLP1 and p80 is indicated in (C). This region
corresponds to almost the total length of p80.
The Walker's A- and B-box consensus se-
quences for nucleotide binding proteins lie
at amino acids 1181±1187 and 1275±1279,
respectively. The 16 repeats of the WD-40
sequence are depicted by boxes. Restriction
enzymes used are as follows: A, ApaI; B,
BamHI; E, EcoRI; H, HindIII; K, KpnI; Sc, SacI;
SII, SacII; S, SmaI; and X, XhoI.
(B) Putative four 30-amino acid repeats at the
N-terminus of the rTLP1 protein.
(C) The rTLP1 protein and the Tetrahymena
p80 amino acid sequences were aligned by
the ClustalW 1.6 program. Identical amino
acids and conserved amino acids are shown
by heavy and light shades, respectively. The
potential metal-binding motif, CxxC(27)CxxC,
reported to be present in p80 by a previous
study (Collins et al., 1995), is found at the
residues 537±570 of p80 amino acid se-
quence. No corresponding metal-binding
motif was found in the TLP1 amino acid se-
quence.
(D) The 16 WD-40 repeats shown in Figure
2A are aligned along with the reported con-
sensus sequence (Neer et al., 1994). (c) and
(F) indicate any hydrophobic and aromatic
amino acid, respectively, and (T) designates
Thr or Ser. The positions of the putative four
b-strand sheets, which were deduced from
the WD-40 repeats of the b subunit of the
heterotrimeric G protein complex whose
crystal structure was recently resolved (Wall
et al., 1995; Sondek et al., 1996), are indicated
above.
fractions. In all cases, the rTLP1 protein was detected see Figure 7). The 55 kDa protein was found to be a
degradative product derived from the 240 and 230 kDain the telomerase-active fractions at concentrations cor-
responding to the relative telomerase activity. Figure 4 proteins (hereafter designated as p240 and p230, re-
spectively) by the heat treatment of the samples in theshows the rTLP1 proteins and the telomerase activity
of the fractions obtained in the final step of purification presence of reducing agents for SDS±PAGE analyses.
The relative concentrations of these proteins showed aby glycerol-gradient centrifugation.Three kindsof rTLP1
proteins, having apparent molecular masses of 240, 230, good correlation with the telomerase titers obtained for
each fraction. The protein that migrated slightly slowerand 55kDa, were detected in the telomerase-active frac-
tions (For a better separation between p240 and p230, than the 120 kDa marker protein in fractions 1±5 was
Mammalian Telomerase Gene TLP1
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Figure 3. Immunoprecipitation Analysis of the Transiently Ex-
pressed rTLP1 Proteins
COS7 cells were transfected either by the expression plasmid vector
that produced the full-length rTLP1 protein fused with the anti-FLAG
at its C-terminus (lanes 2 and 4) or by the plasmid without the insert
cDNA (lanes 1 and 3). These cells were metabolically labeled with Figure 5. Immunoprecipitation of the Rat Telomerase Activity by
[35S]methionine and cysteine. Total cell lysates were prepared and the Anti-rTLP1 Antibody
immunoprecipitated either by the anti-FLAG antibody (lanes 1 and An S100 extract was prepared from rat AH66F cells. It was immuno-
2) or the affinity-purified anti-rTLP1 antibody (lanes 3 and 4). The precipitated either by the preimmune IgG (lanes 2 and 3) or the
immunoprecipitates were analyzed by SDS-PAGE and autoradiog- anti-rTLP1 antibody (lanes 4 and 5). The immune complexes were
raphy. The rTLP1 protein p240 was specifically detected in the absorbed by Protein A±Sepharose. The supernatants (lanes 2 and
cDNA-transfected cells by both the anti-FLAG antibody and anti- 4) and the absorbed fractions (lanes 3 and 5), along with the original
rTLP1 antibody (indicated as p240). S100 extract, were assayed for telomerase activity. Owing to limited
sample volumes, only one-fifth of each supernatant sample was
used in the assays. Therefore, a direct quantitative comparison is
thought to be unrelated to the TLP1 protein, because not possible between lanes 1, 3, and 5 and lanes 2 and 4. In order
another anti-rTLP1 antibody did not recognize this pro- to show the weak activity detected in lane 3, an autoradiograph
after a long exposure is shown here.tein. In summary, the rTLP1 proteins p240 and p230 were
shown to be consistently copurified with telomerase
activity in a series of extensive purification experiments. specific volume and a friction coefficient similar to these
Three marker proteins, thyroglobulin (19.3 S, 669 kDa), marker proteins, the molecularmass of theenzyme com-
catalase (11.3 S, 232 kDa), and aldolase (7.6 S, 158 kDa), plex is estimated to be about 1500 kDa.
were centrifuged in an identical glycerol gradient. The To obtain further evidence that the rTLP1 protein is a
sedimentation coefficient of the rat telomerase was cal- component of telomerase, we next examined the ability
culated to be 44 S from the migration rates of these of the antibody to immunoprecipitate rat telomerase
activity (Figure 5). An S100 extract derived from the ratmarker proteins. Assuming that telomerase has a partial
Figure 4. Detection of the rTLP1 Proteins
p240 and p230 in the Rat Telomerase Sam-
ples Purified by Glycerol-Gradient Centrifu-
gation
The rat telomerase purified by heparin-Seph-
arose, anion-exchange, hydroxyapatite, and
metal-chelate chromatography was further
purified by glycerol-gradient centrifugation.
(A) The telomerase activity of each fraction
was assayed using the stretch PCR assay.
(B) The quantitated telomerase activity is de-
picted in the top panel, and the rTLP1 pro-
teins p240 and p230 detected by Western
blotting are shown in the bottom panel for
each purified fraction. The sedimentation po-
sitions of the standard proteins are shown at
the top. The positions of p240, p230, and p55
are indicated on the right.
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Figure 6. Northern Blotting Analysis of Mouse Tissues
A membrane blotted with 2 mg of each poly(A)1 RNA derived from
the mouse tissues indicated above (Clontech) was hybridized with
the rat TLP1 probe. Similar levels of the b-actin transcript were
detected in all lanes when hybridized with the actin probe (data not
shown), indicating that similar levels of mRNA from the different
tissues were loaded. The positions of the 9.5 and 7.5 kb RNA molec-
ular weight markers are indicated on the left.
hepatoma cell line AH66F showed strong telomerase
activity (Figure 5, lane 1). When the extract was treated
with the preimmune IgG, no significant telomerase activ-
ity was detected in the fraction immunoprecipitated by
Protein A Sepharose (Figure 5, lane 3), and most activity
remained in the unbound fraction (Figure 5, lane 2). In
contrast, when the extract was immunoprecipitated by
the anti-rTLP1 antibody, a significant level of telomerase
activity was detected in the immunoprecipitated fraction
Figure 7. Posttranslational Modification of rTLP1 and the Telo-
(Figure 5, lane 5), although considerable activity still merase Activity
remained in the unbound fraction (Figure 5, lane 4). (A) AH66F cells were labeled by [35S]methionine and cysteine for 30
Quantitative analysis indicated that the antibody immu- min (pulse) and chased for 0, 1, 3, or 6 hr in complete medium
noprecipitated about 15%±20%of the total activitypres- supplemented with 2.5 mM methionine. The labeled extracts were
immunoprecipitated using the anti-rTLP1 antibody.The immunopre-ent in the S100 sample. A similar result was obtained
cipitates were analyzed by SDS-PAGE and autoradiography. Anwith the highly purified rat telomerase samples shown
extract obtained from cells labeled for 6 hr without chase was alsoin Figure 3B (data not shown). In these experiments,
analyzed (lane C, control). The positions of p240 and p230 are indi-
we were unable to immunoprecipitate all the activity; cated. p240 was modified to p230 within a 3 hr chase after pulse
significant levels of activity always remained in the un- labeling.
bound fractions. Western blotting analysis, however, (B) S100 extracts were prepared from AH66F cells and rat liver,
kidney, and testis. Extracts derived from the same wet weights ofidentified the rTLP1 proteins present in these unbound
cells were analyzed quantitatively for telomerase activity by thefractions. Therefore, the failure to absorb all the activity
stretch PCR assay (upper panel) and for p240 and p230 by Westernin these immunoprecipitation experiments did not nec-
blotting (lower panel). The positions of p240 and p230 are indicated.
essarily indicate the presence of a subset of telomerase
that did not contain rTLP1 proteins. Taken together,
these results indicate that the rTLP1 products p240 and in this study suggests that telomerase activity is not
p230 are component of, or are closely associated with, regulated by the expression of the TLP1 gene.
the rat telomerase.
Modification of rTLP1 p240 to p230 May
Regulate the Telomerase ActivityUbiquitous Expression of TLP1 Gene
in Mouse Tissues To analyze the relationship between p240 and p230, we
performed a pulse±chase experiment. AH66F cells wereWe examined the expression of the TLP1 gene by a
Northern blotting analysis in mouse (Mus musculus) tis- pulse labeled with [35S]methionine for 30 min, followed
by the addition of excess cold methionine. Cells weresues, including heart, brain, spleen, lung, liver, skeletal
muscle, kidney, and testis (Figure 6). In all tissues except further cultured for chase times of 0, 1, 3, and 6 hr, and
the total cell lysates were then prepared for SDS±PAGEthe brain, a 9 kb mRNA was easily detected in 2 mg of
poly(A)1 RNA. A relatively weak level of expression in and autoradiography (Figure 7A). Immediately after the
pulse labeling (0 hr chase), it was observed that the levelbrain tissues was also found in human brain tissue when
the human TLP1 gene was used as a probe (unpublished of p240 was greater than p230. However, as the chase
time was extended from 1 to 6 hr, the p230 fractiondata). Interestingly, another small 5 kb TLP1 mRNA was
found to be specific in heart tissue. We have not yet gradually increased and the p240 fraction decreased.
At 3 and 6 hr chase times, the p230 fraction was greaterelucidated the structural difference between this small
transcript and the widely observed 9 kb transcript. It has than p240 and similar to that observed with stably la-
beled cells (Figure 7A, lane C, control), suggesting thatbeen reported that no telomerase activity is detected in
the mouse kidney or brain (Prowse and Greider, 1995). the change from p240 to p230 is completed within 3
hr of translation. This experiment clearly indicated thatThe presence of the TLP1 transcript in kidney observed
Mammalian Telomerase Gene TLP1
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p230 is a mature form derived from p240. At present, emphasize that the final verification of the identified
clones requires biochemical evaluation. In our case, thewe do not know whether posttranslational modification
or cleavage of the protein is responsible for this change. newly developed stretch PCR assay was a key to this
process.COS7 cells transfected by the rTLP1 cDNA and tran-
siently over-expressing the rat TLP1 protein dominantly
produced p240 and a relatively small amount of p230 TLP1 Protein as a Component of Telomerase
(Figure 3). This result suggested that the COS7 cells All the results obtained in this study strongly suggested
were not competent to modify the large amount of p240 that the TLP1 protein, a mammalian homolog of Tetrahy-
produced by the expression vector. mena p80, is a protein component of telomerase. First,
Since our results suggested that the telomerase activ- the TLP1 proteins p240 and p230 were copurified with
ity is not regulated by TLP1 expression, it was interesting telomerase activity in different purification steps by dif-
to examine whether modification of the rTLP1 proteins ferent methods of separation. Second, immunoprecipi-
is related to activity. Rat liver, kidney, and testis tissues tation experiments indicated that the TLP1 protein is
were assayed for telomerase activity using the stretch closely associated with the active telomerase. Third,
PCR assay and examined for p240 and p230 abundance modification of the TLP1 protein appeared to correlate
by Western blotting analysis (Figure 7B). To avoid possi- with the telomerase activity. Finally, we found that the
ble contamination of the genomic DNA and telomerase TLP1 proteins were among the major proteins present in
inhibitors, the cell extract was partially purified on a the highly purified telomerase preparation (unpublished
heparin Sepharose column for the quantitative analysis data). However, the possibility that the TLP1 protein is
of telomerase activity. In the liver and testis extracts, closely associated with, butnot essential for, telomerase
about 20% and 45% levels of activity were detected, activity is still present. The answer to this question will
respectively, as compared to that of the control AH66F only be obtained by a reconsititution experiment using
cells extract . In contrast, only a negligible level of activ- all the components, which is not possible at present.
ity was found in the kidney extract. The TLP1 proteins It is not known how many protein components com-
were detected in all tissues. This result confirmed the prise the catalytically active mammalian telomerase
hypothesis that the expression of the TLP1 gene does complex. However, a glycerol-gradient centrifugation
not control telomerase activity. However, the relative experiment suggested that the molecular mass of telo-
abundance of p240 and p230 differed depending on the merase is more than 1000 kDa. Although the rat te-
tissues tested. In the telomerase-negative kidney, p240 lomerase RNA component is not known, the mouse RNA
was the predominant form, with only a relatively small (mTR) is about 450 nt, and the calculated molecular
amount of p230 present. In contrast, p230 was more mass is about 150 kDa (Blasco et al., 1995). Thus, it is
abundant in the telomerase-positive testis. The liver, likely that another protein component(s), in addition to
which had a moderate level of telomerase activity, dis- the TLP1 protein, is necessary for the active telomerase.
played an intermediate pattern, with similar levels of One such protein may be a mammalian homolog of
p240 and p230. Finally, a very high level of p230 was Tetrahymena p95.
present in the AH66F cells. These results suggested
that the modified p230 is associated with the active
Possible Functions of the TLP1 Proteintelomerase, whereas the p240 precursor is associated
The finding that TLP1 encodes a large 290 kDa proteinwith an inactive form.
containing a nucleotide binding domain and WD repeats
was unexpected. It was reported that Tetrahymena telo-
merase p80 and p95 bind to each other by protein±Discussion
protein interactions, even in the absence of the RNA
component (Collins et al., 1995). The TLP1 protein con-We successfully identified a mammalian homolog by a
BLAST search of the EST database using the Tetrahy- tains a region of length equivalent to p80 in its amino-
terminal one-third. This region may play all the rolesmena p80 sequence. This study illustrates the use-
fulness of the informatics of the genome project. Several performed by Tetrahymena p80, including the interac-
tion with the putative p95 homolog. If this is the case,lessons were learned here. First, the presumed orienta-
tion of the ORF reported with each EST clone is not the nucleotide binding domain and WD repeats found
in the TLP1 protein might perform serve functions spe-necessarily correct. Second, the EST clone may have
intron sequences, disrupting the continuity of the antici- cific to mammalian telomerases. Alternatively, there
might be a Tetrahymena protein that has not yet beenpated ORFs. Apparent ªjunkº candidates should not be
discarded in a database search simply because of these identified and that plays similar roles to those performed
by these additional mammalian domains.reasons. Finally, a systematic strategy is needed to ex-
tract significant clones from among thenumerous candi- Two possibilities can be inferred about the functions
of the nucleotide binding and WD repeats domains.dates. The method employed here, namely extending
the sequence information of a region of interest by vec- First, it is possible that these domains are involved in the
catalytic activity of the enzyme. These putative functionstorette PCR to see if the homology would significantly
increase over the extended region, was shown to be may include melting the substrate single-stranded telo-
meric DNA and regulation of the telomerase processiv-effective for this purpose. Coupled with this strategy, a
database search may identify a sequence of very weak ity. The second possibility is that these domains do not
directly participate in telomerase activity. The telomerebut significant homology (Figure 2C) that conventional
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(Boehringer-Mannheim). The thermal cycle was 1 min at 938C, 1 minproteins, and has a number of divergent functions. In
at 658C, and 2 min at 728C for 35 cycles, followed by 10 min at 728C.yeast and ciliates, nonnucleosomal domains were iden-
A rat SV-3Y1 cell cDNA library was constructed using the ZAP-tified in the telomeres using structural, functional, and
cDNA synthesis kit (Stratagene). The cDNA with an EcoRI adaptor
biochemical approaches (Gottschling and Cech, 1984; at both ends was ligated to predigested l ZAP II vector. The 1.2 kb
Wright et al., 1992). In human cells, micrococcal PCR fragment clone, V5, was used as a probe for screening 1 3
106 independent clones of the library. Three positive clonesnuclease digestion experiments have indicated the
(rlTLP1±3) were detected by autoradiography and isolated. Restric-presence of an unusual chromatin structure at the very
tion analysis and DNA sequencing of the three positive clones re-ends of the telomere (Tommerup et al., 1994). Telomere
vealed that they were all colinear and derived from the same tran-binding proteins (TBPs) have been identified in several
script, and the 39 ends of these plasmids did not contain poly(A)1
speicies (Fang and Cech, 1995). In mammals, a protein tracts. Further screening of another group of 1 3 106 clones using
named TRF was shown to be specifically localized at the 39-end fragment of rlTLP3, the longest cDNA clone, identified
10 positive clones. Restriction analysis and DNA sequencing of 6the telomeres (Chong et al., 1995). These proteins are
of these clones revealed that 3 clones (rlTLP01, -09, and -13) hadpresumably members of the large telomeric domain
the same 39-end sequence followed by different lengths of poly(A)1called the telosome (Wright and Zakian, 1995). Several
tract, indicating the 39 end of the cDNA.lines of evidence have suggested that TBPs play a role
The 59 end of the cDNA clone was obtained by a 59 RACE experi-
in regulating the telomerase activity in vivo (Runge and ment according to the the manufacturer's directions (Clontech). The
Zakian, 1989; Krauskopf and Blackburn, 1996; for re- four oligonucleotides used were NcEX3 (59-GATCCATGGTCAG
CTAATTATGGCCTTTGGAGCTTCATCCGTT- 39), PC5 (see above),view, see Greider, 1996). Therefore, it is possible that
RACE-ANC (59-CACGAATTCACTATCGATTCTGGAACCTTCAAGG-telomerase has either direct or indirect interactions with
NH2-39), and RACE-PRM (59-TAAGCTTCCTCTGAAGGTTCCAGAATTBPs. The WD repeats in the TLP1 protein might play
CGATAG-39).a role as an interface between the telomerase and other
protein members of the telosome. In this respect, it is
Antibodyof interest that the TLP1 protein is constitutively ex-
A PCR fragment encoding amino acids 241±490 of the rTLP1 waspressed in most tissues. The inactive TLP1 p240 may
subcloned into pET-32a (Novagen), which is designed to producefunction as a ªplatform proteinº mediating the assembly
a thioredoxin fusion protein that contains a 6-histidine tag. The
of the various proteins, including telomerase and TBPs, plasmid was introduced into the E. coli strain BL21 (DE3). After
at the telosome. When p240 is activated to p230, the disrupting the bacterial cells by sonication, the recombinant protein
was isolated as inclusion bodies and treated with 8M-UTS buffercomposition of and interactions among the members of
(20 mM Tris±HCl [pH 7.5], 0.5 M NaCl, 8 M urea). The solubilizedthe telosome may change, leading to the activation of
recombinant protein was then loaded on an Ni21-bound HiTrap Che-the telomerase. This type of regulatory role in a signaling
lating column (Pharmacia). The column was washed with 6M-UTP8pathway has been described for the b subunit of the
buffer (6 M urea, 0.1 M NaH2PO4, 10 mM Tris±base, pH adjusted toheterotrimeric G proteins, which is the prototype of the 8.0 with NaOH), and the protein was eluted by a pH gradient to 6M-
WD repeats proteins (Neer, 1995). UTP3 buffer (6 M urea, 0.1 M NaH2PO4, 10 mM Tris±base, pH ad-
justed to 3.0 with HCl). The eluted material was mixed in a 1:1 ratio
with Freund's adjuvant and injected into New Zealand white rabbits
Experimental Procedures in 3 3 100 mg doses.
The affinity column used for purification of the anti-TLP1 antibody
Cells from immune sera was prepared as described below. A restriction
Adenovirus- and SV-40-transformed rat 3Y1 fibroblast cell lines (Ad- fragment (HindIII±SacI site) encoding the 217±481 amino acid se-
3Y1 and SV-3Y1) and African green monkey kidney COS7 cells were quence of rTLP1 was inserted into pGEX (Pharmacia)and introduced
grown in Dulbecco's modified Eagles medium supplemented with into the E. coli strain XL1-Blue MRF9. The bacterial extracts were
10% fetal bovine serum. The rat hepatoma cell line AH66F was prepared in lysis buffer (20 mM Tris-HCl [pH 7.5], 300 mM NaCl, 20
grown in RPMI1640 medium supplemented with 10% fetal bovine mM EDTA, 10% w/v sarcosyl) by disrupting cells by sonication and
serum. clarifying the supernatant by centrifugation at 12,000 3 g for 5 min.
The supernatant was then loaded onto a Glutathione Sepharose 4B
column and eluted with GST elution buffer (75 mM HEPES [pH 8.0],
Cloning of rTLP1 cDNA 75 mM NaCl, 5 mM DTT, 0.01% Triton X-100, 20 mM reduced gluta-
An oligonucleotide primer PC5 (59-CATACCTGGTAGAACTCGG thione). The eluted recombinant protein was concentrated and
CTA-39) was constructed according to the reported sequence of crosslinked to NHS-activated HiTrap, as recommended by the sup-
H33937. Vectorette PCR was performed as described (Riley et al., plier (Pharmacia). The immune sera was loaded onto the affinity
1994) using adaptor primers VCT-A (59-AAGGAGAGGACGCTGT column, and the bound antibody was eluted using elution buffer
CTGTCGAAGGTAAGGAACGGACGAGAGAAGGGAGAG-39), VCT-B (0.1 M glycine-HCl [pH 2.5]). After neutralization with 1 M Tris±base,
(59-CTCTCCCTTCTCGAATCGTAACCGTTCGTACGAGAATCGCTGT the purified anti-TLP1 antibody was used for Western blotting and
CCTCTCCTT), and VCT-G (59-CGGTACCGAATCGTAACCGTTCG immunoprecipitation. For control experiments, preimmune IgG was
TACGAGAATCGCT). The template cDNA for the vectorette PCR was purified using a HiTrap protein G column according to the manufac-
synthesized from 1 mg of Ad-3Y1 poly(A)1 RNA. The first strand turer's directions (Pharmacia).
cDNA was synthesized using SuperScript reverse transcriptase
(GIBCO-BRL) and random primer (hexadeoxyribonucleotide mix-
ture; TaKaRa). After the synthesis of the second strand cDNA, an Transient Expression of rTLP1 Protein in COS Cells
The full-length rTLP1 cDNA was introduced into the mammalianaliquot of double-stranded cDNA (5 ml of total 160 ml reaction vol-
ume) was digested with PvuII. These blunt-ended cDNA fragments expression vector pcDNA3-FLAG, which had a FLAG epitope se-
quence at the 39 end of the MCS of original vector pcDNA3 (In-were then ligated with 3 pmol of annealed bubble oligonucleotides,
which consisted of the two oligonucleotides VCT-A and VCT-B. vitrogen). The resultant plasmid, pcRTLP1, produced the full-length
TLP1 protein with a FLAG tag (DYKDDDK) at the C-terminus. Trans-Using an aliquot of bubble-ligated cDNA (1 ml of total 50 ml ligation
volume) as the template, vectorette PCR was carried out in a 50 ml fection of COS7 cells was performed by calcium phosphate precipi-
tation. Five hours after transfection, the medium was replaced withreaction volume containing 0.4 mM of H33937-specific primer (PC5),
0.4 mM of VCT-G primer, 0.2 mM dNTPs, 0.5% polyoxyethylene prewarmed culture medium, and the cells were incubated for an-
other 48 hr before harvesting.ether W-1 (Sigma), 13 PCR buffer, and 2.5 U of Taq polymerase
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